Thermo Fisher Scientific Inc. Receives High Growth Rating

Thermo Fisher Scientific Inc. receives a 69% rating in the Growth Investor model based on its strong fundamentals and stock valuation, highlighting significant interest from investors. This stock shows solid growth despite some weaknesses.

Date: 11-03-2025

AI Rating: 7

Key Insights on Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO) has demonstrated noteworthy performance in several key areas. The report indicates that TMO has successfully passed critical metrics associated with the Growth Investor strategy. These include:

P/E Ratio: Pass
Revenue Growth in Relation to EPS Growth: Pass
Sales Growth Rate: Pass
Current Quarter Earnings: Pass
Quarterly Earnings One Year Ago: Pass
Positive Earnings Growth Rate for Current Quarter: Pass
EPS Growth for Current Quarter Must Be Greater Than Prior 3 Quarters: Pass
EPS Growth for Current Quarter Must Be Greater Than the Historical Growth Rate: Pass
Insider Transactions: Pass

The positive evaluations listed suggest a robust growth trajectory, particularly in revenue and EPS growth relative to previous periods. However, the report also highlights significant challenges.

Earnings Growth Rate for the Past Several Quarters: Fail
Earnings Persistence: Fail
Long-Term EPS Growth: Fail
Total Debt/Equity Ratio: Fail

The failures in key metrics related to earnings growth and debt raise concerns over the company's long-term stability despite its current strength. Investors may find the strong pass scores compelling, yet they should be cautious regarding the potential impact of these weaknesses over time. In summary, TMO reflects a mixed outlook for investors, combining promising growth characteristics with notable red flags that could influence stock price dynamics.

Stocks: TMO